State Ledger
Company profile

Avalo Therapeutics, Inc. CIK 1534120

Ticker
AVTX (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Wayne, PA 19087
Fiscal year end
2025 (FY)
Market Data
Close
$13.65
Change
+$0.23
Change %
1.68%
Volume
43,533

AVTX · trading date Oct 9, 2026 · previous close $13.43 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$59.0K
Net income
-$78.26M
Total assets
$116.46M
Total liabilities
$33.41M
Stockholders' equity
$83.05M
Cash & equivalents
$15.86M
Operating income
-$72.93M
Operating cash flow
-$51.46M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-23. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-123,601.7%
Net margin
-132,642.4%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
28.7%
Equity / assets
71.3%
CapEx / revenue
—
Operating cash flow / net income
0.66×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $59.0K -$78.26M $116.46M $33.41M $83.05M
2024 $441.0K -$35.13M $150.73M $17.70M $133.03M
2023 $1.92M -$31.54M $20.99M $13.69M $7.30M
2022 $18.05M -$41.66M $33.37M $44.28M -$10.92M
2021 $5.40M -$84.38M $80.21M $57.13M $23.08M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-23

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Wayne, PA 19087
1500 LIBERTY RIDGE DRIVE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:52 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Pennsylvania — Public Companies